Why is Strides Pharma falling/rising?

As of 16-Jul, Strides Pharma Science Ltd is experiencing a price increase, with its current price at 925.10, reflecting a rise of 17.05 (1.88%). The stock has recently reached a new 52-week high of Rs. 955.5, indicating strong performance, as it outperformed its sector by 2.15% today. Over the past week, the stock has gained 5.90%, and it has shown impressive returns over longer periods, including a 104.24% increase over the past year. The company's financial health is robust, with a significant net profit growth of 81.62% and positive results for the last seven consecutive quarters, contributing to its attractive valuation compared to peers.
In the broader market context, while Strides Pharma has shown strong short-term performance, the benchmark Sensex has declined by 1.08% over the past week. This contrast highlights the stock's resilience and ability to generate returns despite a challenging market environment. The stock's liquidity remains adequate, although there has been a slight decline in investor participation, with delivery volume falling by 17.23% against the five-day average. Overall, the combination of strong financial results and consistent returns over the past three years supports the stock's upward movement, distinguishing it from the broader market trends.